Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03263026
Title Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Denovo Biopharma LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.